Table of Contents
About This Report The Canadian generic drugs industry faces a number of challenges, although provinces are now implementing strategies to increase competition in the industry, and provide greater opportunities for smaller generic drugs players. In terms of biosimilars, referred to as subsequent entry biologics (SEBs), Health Canada in March 2010 published its regulatory guidance for the approval of SEBs. What's Included i...More »
The Largest Collection of Market Research Reports
From +200,000 authoritative sources
Talk to Louis
+1 718 618 4302
STUDY GOALS AND OBJECTIVES The aim of this report is to provide detailed market, technology and industry analyses to help readers quantify and qualify the market for prescription generic drugs. Important ...
... September 2012) why now Office of generic drugs (ogd)/fda has been significantly under resourced for more than a decade the pharmaceutical industry has globalized requiring fda oversight ...
Reportlinker.com © Copyright 2014. All rights reserved.